Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia

QR Code (код быстрого отклика)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia

The study aimed to perform a pharmacoeconomic analysis of antimicrobial drugs (AMDs) prescribed for the treatment of community-acquired pneumonia (CAP) in outpatient conditions.Materials and methods. 650 medical histories of patients aged 18 to 65 years old with a diagnosis of CAP who received outpa...

Полное описание

Сохранить в:

Библиографические подробности
Главные авторы:	V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura
Формат:	Статья
Язык:	русский
Опубликовано:	IRBIS LLC 2021-02-01
Серии:	Фармакоэкономика
Предметы:	community-acquired pneumonia pharmacoeconomics antimicrobial drugs general medical practice outpatient treatment rational pharmacotherapy
Online-ссылка:	https://www.pharmacoeconomics.ru/jour/article/view/449
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
по: A. A. Taube, и др.
Опубликовано: (2023-11-01)

Modern characteristics of publicly acquired pneumonia caused by Clamydophyla pneumoniae
по: A. I. Danilov, и др.
Опубликовано: (2021-06-01)

ADJUNCTIVE THERAPY OF COMMUNITY-ACKUIRED PNEUMONIA: NECESSITY AND SUFFICIENCY
по: L. V. Savchenkova, и др.
Опубликовано: (2016-12-01)

Problems of choosing antimicrobial therapy in young children with community-acquired pneumonia
по: Z. A. Shangareeva, и др.
Опубликовано: (2025-03-01)

RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA
по: T. Vekov
Опубликовано: (2015-09-01)

Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects)
по: O. V. Zhukova, и др.
Опубликовано: (2018-05-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
по: Matteo Bassetti, и др.
Опубликовано: (2025-04-01)

PHARMACOECONOMIC EVALUATION OF ANTI-PNEUMOCOCCAL VACCINATION IN RISK GROUPS FOR THE PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA AMONG ADULTS IN THE ASTRAKHAN REGION
по: E. A. Orlova, и др.
Опубликовано: (2021-05-01)

Hospital-acquired pneumonia: risk factors and prognosis, microbial etiology, treatment, and prophylaxis
по: Davide Calabretta, и др.
Опубликовано: (2025-04-01)

Barriers to Compliance with National Guidelines Among Children Hospitalized with Community-Acquired Pneumonia in Vietnam and the Implications
по: Thuy Thi Phuong Nguyen, и др.
Опубликовано: (2025-07-01)

Cytokine profile in community-acquired pneumonia in children
по: N. V. Iziurova, и др.
Опубликовано: (2022-11-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
по: N. V. Iziurova, и др.
Опубликовано: (2024-01-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
по: A. V. Martynova, и др.
Опубликовано: (2014-06-01)

Antibacterial Therapy of Severe Community-Acquired Pneumonia in Adults - Is There a Need for New Drugs?
по: S. A. Rachina, и др.
Опубликовано: (2020-05-01)

The Role of Ultrasound in Diagnosing Community-Acquired Pneumonia
по: D. O. Starostin, и др.
Опубликовано: (2023-02-01)

Antibiotic Therapy of Severe Community-Acquired Pneumonia
по: O. V. Molchanova, и др.
Опубликовано: (2020-05-01)

Effect of vaccination on morbidity and mortality from community-acquired pneumonia
по: T. A. Bayanova, и др.
Опубликовано: (2024-03-01)

Modern approaches at the management of children with community-acquired pneumonia
по: Aleksander A. Baranov, и др.
Опубликовано: (2023-03-01)

Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management
по: Ruta Nutautiene, и др.
Опубликовано: (2025-06-01)

Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
по: V. I. Sakharov, и др.
Опубликовано: (2020-12-01)

Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities
по: R. E. Kalinin, и др.
Опубликовано: (2023-07-01)

DDD and DU90% Analysis of Antimicrobial Therapy of Community-Acquired Pneumonia in the In-Patient Department of the Federal Center
по: O. V. Zhukova, и др.
Опубликовано: (2020-05-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
по: L. A. Demidchik, и др.
Опубликовано: (2016-05-01)

ANTIMICROBIAL RESISTANCE OF <i>Klebsiella pneumonia</i> ISOLATES IN REPUBLIC OF SAKHA (YAKUTIA)
по: O. M. Egorova, и др.
Опубликовано: (2019-02-01)

Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis
по: Catia Cilloniz, и др.
Опубликовано: (2025-04-01)

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
по: L. R. Mukhamadieva, и др.
Опубликовано: (2014-07-01)

Prognostic value of peripheral blood lymphocytes in community-acquired pneumonia in children
по: N. V. Iziurova, и др.
Опубликовано: (2025-06-01)

Discussion questions about community-acquired pneumonia in children
по: N. A. Geppe, и др.
Опубликовано: (2014-03-01)

Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
по: O. V. Molchanova, и др.
Опубликовано: (2020-05-01)

Assessment of the prognosis of the outcome of severe community-acquired pneumonia caused by <i>Klebsiella pneumoniae</i>
по: V. I. Sakharov, и др.
Опубликовано: (2023-12-01)

THE ANALYSIS OF THE COMMUNITY-ACQUIRED PNEUMONIA COURSE IN CHILDREN OF ROSTOV-ON-DON
по: O. E. Semernik, и др.
Опубликовано: (2019-03-01)

Features of the clinical presentation and course of community-acquired pneumonia against the background of type 2 diabetes mellitus
по: A. A. Zaytseva, и др.
Опубликовано: (2022-07-01)

Platelet variables in community-acquired pneumonia in children with respiratory infections
по: E. A. Kozyrev, и др.
Опубликовано: (2022-04-01)

Use of medications in children hospitalized with community-acquired pneumonia
по: D. D. Siukaeva, и др.
Опубликовано: (2018-11-01)

Calculation of epidemic thresholds for incidence of community-acquired pneumonia
по: A. D. Botvinkin, и др.
Опубликовано: (2022-06-01)

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.
по: Ya. O. Dziublyk
Опубликовано: (2014-06-01)

Cytokine profile of bronchoalveolar secretion in prolonged course of community acquired pneumonia
по: R.V. Razumnyi
Опубликовано: (2022-03-01)

Inhaled Polymyxin in Treatment of Elderly Patients with Severe Community-Acquired Klebsiella pneumoniae-Induced Pneumonia
по: V. I. Sakharov, и др.
Опубликовано: (2020-12-01)

Comparative effect of immunomodulators on the contents of hydrolase inhibitors and lactoferrin in community-acquired pneumonia in adults
по: M. P. Kostinov, и др.
Опубликовано: (2020-08-01)

The Practice of Antibiotic Therapy of Severe Community-Acquired Pneumonia in Adults in Russian Multidisciplinary Hospitals
по: S. A. Rachina, и др.
Опубликовано: (2022-04-01)